title: Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007.
abstract: BACKGROUND
  Overuse of antibiotics is the main force driving the emergence and dissemination of bacterial resistance in the community. France consumes more antibiotics and has the highest rate of beta-lactam resistance in Streptococcus pneumoniae than any other European country. In 2001, the government initiated "Keep Antibiotics Working"; the program's main component was a campaign entitled "Les antibiotiques c'est pas automatique" ("Antibiotics are not automatic") launched in 2002. We report the evaluation of this campaign by analyzing the evolution of outpatient antibiotic use in France 2000-2007, according to therapeutic class and geographic and age-group patterns.
  
  
  RESULTS
  This evaluation is based on 2000-2007 data, including 453,407,458 individual reimbursement data records and incidence of flu-like syndromes (FLSs). Data were obtained from the computerized French National Health Insurance database and provided by the French Sentinel Network. As compared to the preintervention period (2000-2002), the total number of antibiotic prescriptions per 100 inhabitants, adjusted for FLS frequency during the winter season, changed by -26.5% (95% confidence interval [CI] -33.5% to -19.6%) over 5 years. The decline occurred in all 22 regions of France and affected all antibiotic therapeutic classes except quinolones. The greatest decrease, -35.8% (95% CI -48.3% to -23.2%), was observed among young children aged 6-15 years. A significant change of -45% in the relationship between the incidence of flu-like syndromes and antibiotic prescriptions was observed.
  
  
  CONCLUSIONS
  The French national campaign was associated with a marked reduction of unnecessary antibiotic prescriptions, particularly in children. This study provides a useful method for assessing public-health strategies designed to reduce antibiotic use.
authors.affiliation: INSERM, U657, Paris, France.
authors.forename: Elifsu
authors.initials: E
authors.lastname: Sabuncu
authors.forename: Julie
authors.initials: J
authors.lastname: David
authors.forename: Claire
authors.initials: C
authors.lastname: Bernède-Bauduin
authors.forename: Sophie
authors.initials: S
authors.lastname: Pépin
authors.forename: Michel
authors.initials: M
authors.lastname: Leroy
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Boëlle
authors.forename: Laurence
authors.initials: L
authors.lastname: Watier
authors.forename: Didier
authors.initials: D
authors.lastname: Guillemot
mesh_terms: D000293:Adolescent; D017677:Age Distribution; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization / Q000639:trends*; D005602:France; D006291:Health Policy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D010818:Practice Patterns, Physicians' / Q000639:trends*; D015397:Program Evaluation; D011634:Public Health
chemical_list: D000900:Anti-Bacterial Agents